WHO WE HELP / LIFE-SCIENCES TECHNOLOGY

Test the product against real drug-development work

RegulatoryX supplies the domain framing, expert network and evaluation discipline that life-sciences AI and digital-health products need before a compelling demo becomes a trusted workflow.

WORKING METHOD
01Tasks
02Rubrics
03Trust
FocusDecision-ready direction
01

WHERE BUILDERS NEED SPECIALIST HELP

Evaluation for builders, assurance for adopters

01

Representative tasks

Realistic, appropriately bounded work drawn from regulatory, clinical, biomarker, writing and evidence contexts.

02

Expert rubrics

Clear definitions of good reasoning, evidence use, uncertainty and escalation behaviour.

03

Blinded evaluation

Multiple expert reviews, adjudicated disagreement and analysis of recurring failure modes.

04

Workflow fit

Where the product belongs, what it replaces, what must remain human, and which controls are essential.

02

WHY REGULATORYX

Not a broad expert marketplace

  • Drug-development work is cross-functional, regulated and context-dependent
  • The person designing the evaluation understands why the answer matters
  • The network provides the depth and scale to test it at pace
  • Every evaluation is delivered with named human accountability

START WITH THE CONSTRAINT

What is slowing your programme — or which capability is your team missing?

Tell us the decision, deliverable or role you are working through. We will help identify the most useful next step.

REGULATORY STRATEGYCLINICAL DEVELOPMENTREGULATORY WRITINGDATADIGITAL R&DSPECIALIST TALENTREGULATORY STRATEGYCLINICAL DEVELOPMENTREGULATORY WRITINGDATADIGITAL R&DSPECIALIST TALENT